BioInvent International AB (publ) (LON:0H22)
London flag London · Delayed Price · Currency is GBP · Price in SEK
33.50
+3.05 (10.02%)
At close: Oct 30, 2025

LON:0H22 Revenue

BioInvent International AB had revenue of 3.32M SEK in the quarter ending September 30, 2025, a decrease of -73.98%. This brings the company's revenue in the last twelve months to 244.85M, up 533.73% year-over-year. In the year 2024, BioInvent International AB had annual revenue of 44.69M, down -37.47%.

Revenue (ttm)
244.85M SEK
Revenue Growth
+533.73%
P/S Ratio
9.14
Revenue / Employee
2.15M SEK
Employees
114
Market Cap
176.70M GBP

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202444.69M-26.78M-37.47%
Dec 31, 202371.46M-254.67M-78.09%
Dec 31, 2022326.13M306.74M1,582.45%
Dec 31, 202119.38M-127.99M-86.85%
Dec 31, 2020147.37M53.63M57.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc31.63B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
ConvaTec Group1.72B
Spire Healthcare Group1.55B
Genus672.80M
Revenue Rankings